Target intelligence / Profile preview

Gamma-aminobutyric acid receptor type A-rho (GABACR)

Target
GABACR
Molecular classification
Ion channel, Ligand-gated ion channel, Cys-loop receptor family, Receptor
01

Overview

The Gamma-aminobutyric acid receptor type A-rho (GABA-A-rho), historically referred to as the GABA_C receptor, is a member of the Cys-loop superfamily of ligand-gated ion channels (IUPHAR/BPS Guide to Pharmacology). It is primarily composed of rho (ρ1, ρ2, and ρ3) subunits that form functional homomeric or heteromeric pentamers, which are distinct from classical GABA_A receptors due to their lack of sensitivity to bicuculline and benzodiazepines (Enz, 2001). These receptors function as chloride-selective channels that mediate slow, sustained inhibitory neurotransmission in the central nervous system, with particularly high expression in the retinal bipolar and horizontal cells (Johnston, 2002). In the retina, they play a vital role in signal processing, including the regulation of visual sensitivity and temporal resolution (Lukasiewicz, 1996). Beyond vision, GABA-A-rho receptors are involved in sleep-wake regulation and memory modulation within the hippocampus and superior colliculus (Nieto et al., 2011). Dysregulation or mutations in the GABRR genes are associated with visual disorders such as retinitis pigmentosa and myopia, as well as neuropsychiatric conditions like anxiety (Albrecht & Darlison, 1995). Pharmacological agents such as the selective antagonist TPMPA and the agonist CACA are used to study these receptors and are being investigated for their potential therapeutic applications in treating retinal diseases and neuropsychiatric conditions (Chebib & Johnston, 1999).

Other names
GABA_C receptorRho-containing GABA receptorGABRRIonotropic GABA receptor type A-rho
02

Mechanism of action

Ligand-gated chloride channel that mediates inhibitory neurotransmission through hyperpolarization of the postsynaptic membrane upon GABA binding (IUPHAR).

03

Biological functions

Inhibitory neurotransmissionVisual processingSignal transductionRegulation of neuronal excitability
04

Disease associations

Retinitis pigmentosaMyopiaSleep disorderAnxietyCognitive impairment
05

Safety considerations

Visual disturbancesPotential for off-target GABA_A activityLimited blood-brain barrier permeability for some ligands
06

Interacting drugs

TPMPA

5 more in the full profile.

07

Biomarkers

GABRR1 expression levelsElectroretinogram (ERG) components

Beyond the preview

Go deeper on Gamma-aminobutyric acid receptor type A-rho (GABACR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma-aminobutyric acid receptor type A-rho (GABACR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call